T80.82XSBillable
Complication of immune effector cellular therapy, sequela
- Chapter
- 19. Injury, poisoning and certain other consequences of external causes
- Category
- T80
- Effective date
- October 1, 2026
Related codes in category T80
T80Comp following infusion, transfusion and theraputc injectionT80.0Air embolism fol infusion, transfuse and theraputc injectionT80.0XXAAir embolism fol infusion, tranfs and theraputc inject, initYesT80.0XXDAir embolism fol infusion, tranfs and theraputc inject, subsYesT80.0XXSAir emblsm fol infusn, tranfs and theraputc inject, sequelaYesT80.1Vascular comp fol infusion, transfuse and theraputc injectT80.1XXAVascular comp fol infusn, tranfs and theraputc inject, initYesT80.1XXDVascular comp fol infusn, tranfs and theraputc inject, subsYesT80.1XXSVasc comp fol infusn, tranfs and theraputc inject, sequelaYesT80.2Infect following infusion, transfuse and theraputc injectionT80.21Infection due to central venous catheterT80.211Bloodstream infection due to central venous catheter
Frequently asked questions
What is ICD-10 code T80.82XS?
T80.82XS is an ICD-10-CM diagnosis code for Complication of immune effector cellular therapy, sequela.
Is T80.82XS a billable code?
Yes. T80.82XS is billable and specific enough to be used on a claim.
What ICD-10-CM chapter is T80.82XS in?
T80.82XS falls under Chapter 19: Injury, poisoning and certain other consequences of external causes.
When did T80.82XS become effective?
T80.82XS has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.
What other codes are related to T80.82XS?
T80.82XS belongs to category T80, which includes 12 other codes — see the related codes list on this page.
ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.